Form 4: Elanco Animal Health CEO Acquires Deferred Stock Units

Elanco Animal Health's CEO, Jeffrey N. Simmons, acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC filing.

Summary

• On February 21, 2025, Jeffrey N. Simmons, the President, CEO, and Director of Elanco Animal Health Inc., acquired 251.2922 deferred stock units.
• Each deferred stock unit represents the right to receive one share of Elanco's common stock or the cash equivalent.
• The price of the derivative security was $11.02.
• Following the transaction, Simmons beneficially owns 5,955.7313 shares of common stock.
• The deferred stock units will settle in cash or shares of Elanco common stock following termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The CEO's acquisition of deferred stock units suggests confidence in the company's future, which is generally viewed favorably. However, it's a routine transaction, so the impact is moderate.

Positives

• The acquisition of deferred stock units by the CEO demonstrates confidence in the company's future performance.

Future Outlook

The deferred stock units will settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Industry Context

Executive compensation through stock and deferred stock units is a common practice in the animal health industry to align management's interests with those of shareholders.

Comparison to Industry Standards

• Stock-based compensation is a standard practice among publicly traded animal health companies such as Zoetis and IDEXX Laboratories.
• These companies often use a mix of stock options, restricted stock units, and performance-based equity awards to incentivize their executives.
• The specific terms and conditions of these awards, such as vesting schedules and performance targets, can vary widely depending on the company's size, growth prospects, and strategic priorities.

Stakeholder Impact

• The acquisition of deferred stock units by the CEO can positively influence shareholder confidence.

Key Dates